{"entity":{"type":"insider","cik":"0001559537","url":"/insider/0001559537","json_url":"/insider/0001559537.json","name":"Fundaro Paolo","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":22,"n_filings":8,"first":"2013-08-13","last":"2020-08-17","span_basis":"filed_date"},"name_variants":[{"name":"Fundaro Paolo","source":"filing","n_filings":8,"first_seen":"2013-08-13","last_seen":"2020-08-17"}],"transactions":[{"id":2754669,"accession":"0001140361-20-018617","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-20-018617","line_url":"/filing/0001140361-20-018617#line-4","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS, INC.","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559537","owner_name":"Fundaro Paolo","owner_url":"/insider/0001559537","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1235512.0,"shares_display":"1,235,512","price_per_share":46.75,"price_display":"46.75","price_state":"stated","total_value":57760186.0,"total_display":"57,760,186.00","shares_owned_after":4000000.0,"shares_owned_after_display":"4,000,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-08-17","filed_date":"2020-08-17","scope":"insider"},{"id":2754662,"accession":"0001140361-20-018617","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-20-018617","line_url":"/filing/0001140361-20-018617#line-3","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS, INC.","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559537","owner_name":"Fundaro Paolo","owner_url":"/insider/0001559537","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":126888.0,"shares_display":"126,888","price_per_share":50.1459,"price_display":"50.15","price_state":"stated","total_value":6362912.9592,"total_display":"6,362,912.96","shares_owned_after":5235512.0,"shares_owned_after_display":"5,235,512","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-08-17","filed_date":"2020-08-17","scope":"insider"},{"id":2754657,"accession":"0001140361-20-018617","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-20-018617","line_url":"/filing/0001140361-20-018617#line-2","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS, INC.","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559537","owner_name":"Fundaro Paolo","owner_url":"/insider/0001559537","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":54600.0,"shares_display":"54,600","price_per_share":50.5515,"price_display":"50.55","price_state":"stated","total_value":2760111.9,"total_display":"2,760,111.90","shares_owned_after":5362400.0,"shares_owned_after_display":"5,362,400","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-08-14","filed_date":"2020-08-17","scope":"insider"},{"id":2754651,"accession":"0001140361-20-018617","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-20-018617","line_url":"/filing/0001140361-20-018617#line-1","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS, INC.","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559537","owner_name":"Fundaro Paolo","owner_url":"/insider/0001559537","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":83000.0,"shares_display":"83,000","price_per_share":52.5958,"price_display":"52.60","price_state":"stated","total_value":4365451.4,"total_display":"4,365,451.40","shares_owned_after":5417000.0,"shares_owned_after_display":"5,417,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-08-13","filed_date":"2020-08-17","scope":"insider"},{"id":3304578,"accession":"0001559515-20-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001559515-20-000002","line_url":"/filing/0001559515-20-000002#line-1","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS, INC.","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559537","owner_name":"Fundaro Paolo","owner_url":"/insider/0001559537","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":595578.0,"shares_display":"595,578","price_per_share":84.6,"price_display":"84.60","price_state":"stated","total_value":50385898.8,"total_display":"50,385,898.80","shares_owned_after":5500000.0,"shares_owned_after_display":"5,500,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-05-13","filed_date":"2020-05-15","scope":"insider"},{"id":8447945,"accession":"0001144204-19-017102","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-19-017102","line_url":"/filing/0001144204-19-017102#line-1","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS, INC.","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559537","owner_name":"Fundaro Paolo","owner_url":"/insider/0001559537","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2171.0,"shares_display":"2,171","price_per_share":107.4492,"price_display":"107.45","price_state":"stated","total_value":233272.2132,"total_display":"233,272.21","shares_owned_after":11114.0,"shares_owned_after_display":"11,114","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-29","filed_date":"2019-03-29","scope":"insider"},{"id":8949951,"accession":"0001144204-15-044172","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-15-044172","line_url":"/filing/0001144204-15-044172#line-1","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559537","owner_name":"Fundaro Paolo","owner_url":"/insider/0001559537","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":582.0,"shares_display":"582","price_per_share":285.0,"price_display":"285.00","price_state":"stated","total_value":165870.0,"total_display":"165,870.00","shares_owned_after":8221.0,"shares_owned_after_display":"8,221","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-24","filed_date":"2015-07-24","scope":"insider"},{"id":6606644,"accession":"0001144204-14-049047","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-14-049047","line_url":"/filing/0001144204-14-049047#line-2","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559537","owner_name":"Fundaro Paolo","owner_url":"/insider/0001559537","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":324.0,"shares_display":"324","price_per_share":239.49,"price_display":"239.49","price_state":"stated","total_value":77594.76,"total_display":"77,594.76","shares_owned_after":8803.0,"shares_owned_after_display":"8,803","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-11","filed_date":"2014-08-12","scope":"insider"},{"id":6606432,"accession":"0001144204-14-029240","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-14-029240","line_url":"/filing/0001144204-14-029240#line-2","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559537","owner_name":"Fundaro Paolo","owner_url":"/insider/0001559537","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":325.0,"shares_display":"325","price_per_share":232.0,"price_display":"232.00","price_state":"stated","total_value":75400.0,"total_display":"75,400.00","shares_owned_after":1655.0,"shares_owned_after_display":"1,655","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-09","filed_date":"2014-05-09","scope":"insider"},{"id":6262355,"accession":"0001144204-14-010092","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001144204-14-010092","line_url":"/filing/0001144204-14-010092#line-13","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559537","owner_name":"Fundaro Paolo","owner_url":"/insider/0001559537","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":324.0,"shares_display":"324","price_per_share":367.51,"price_display":"367.51","price_state":"stated","total_value":119073.24,"total_display":"119,073.24","shares_owned_after":1655.0,"shares_owned_after_display":"1,655","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-14","filed_date":"2014-02-14","scope":"insider"},{"id":6262353,"accession":"0001144204-14-010092","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001144204-14-010092","line_url":"/filing/0001144204-14-010092#line-12","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559537","owner_name":"Fundaro Paolo","owner_url":"/insider/0001559537","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":370.0,"price_display":"370.00","price_state":"stated","total_value":555000.0,"total_display":"555,000.00","shares_owned_after":6901.0,"shares_owned_after_display":"6,901","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-12","filed_date":"2014-02-14","scope":"insider"},{"id":6262351,"accession":"0001144204-14-010092","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001144204-14-010092","line_url":"/filing/0001144204-14-010092#line-11","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559537","owner_name":"Fundaro Paolo","owner_url":"/insider/0001559537","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":375.0,"price_display":"375.00","price_state":"stated","total_value":375000.0,"total_display":"375,000.00","shares_owned_after":4901.0,"shares_owned_after_display":"4,901","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-12","filed_date":"2014-02-14","scope":"insider"},{"id":6262348,"accession":"0001144204-14-010092","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001144204-14-010092","line_url":"/filing/0001144204-14-010092#line-10","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559537","owner_name":"Fundaro Paolo","owner_url":"/insider/0001559537","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":922.0,"shares_display":"922","price_per_share":383.0,"price_display":"383.00","price_state":"stated","total_value":353126.0,"total_display":"353,126.00","shares_owned_after":1979.0,"shares_owned_after_display":"1,979","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-12","filed_date":"2014-02-14","scope":"insider"},{"id":6262345,"accession":"0001144204-14-010092","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001144204-14-010092","line_url":"/filing/0001144204-14-010092#line-9","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559537","owner_name":"Fundaro Paolo","owner_url":"/insider/0001559537","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":864.0,"shares_display":"864","price_per_share":378.6644,"price_display":"378.66","price_state":"stated","total_value":327166.0416,"total_display":"327,166.04","shares_owned_after":4037.0,"shares_owned_after_display":"4,037","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-12","filed_date":"2014-02-14","scope":"insider"},{"id":6262342,"accession":"0001144204-14-010092","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001144204-14-010092","line_url":"/filing/0001144204-14-010092#line-8","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559537","owner_name":"Fundaro Paolo","owner_url":"/insider/0001559537","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":382.0,"price_display":"382.00","price_state":"stated","total_value":191000.0,"total_display":"191,000.00","shares_owned_after":2901.0,"shares_owned_after_display":"2,901","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-12","filed_date":"2014-02-14","scope":"insider"},{"id":6262339,"accession":"0001144204-14-010092","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001144204-14-010092","line_url":"/filing/0001144204-14-010092#line-7","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559537","owner_name":"Fundaro Paolo","owner_url":"/insider/0001559537","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":381.0,"price_display":"381.00","price_state":"stated","total_value":190500.0,"total_display":"190,500.00","shares_owned_after":3401.0,"shares_owned_after_display":"3,401","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-12","filed_date":"2014-02-14","scope":"insider"},{"id":6262336,"accession":"0001144204-14-010092","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001144204-14-010092","line_url":"/filing/0001144204-14-010092#line-6","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559537","owner_name":"Fundaro Paolo","owner_url":"/insider/0001559537","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":373.0,"price_display":"373.00","price_state":"stated","total_value":186500.0,"total_display":"186,500.00","shares_owned_after":5901.0,"shares_owned_after_display":"5,901","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-12","filed_date":"2014-02-14","scope":"insider"},{"id":6262333,"accession":"0001144204-14-010092","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001144204-14-010092","line_url":"/filing/0001144204-14-010092#line-5","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559537","owner_name":"Fundaro Paolo","owner_url":"/insider/0001559537","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":372.0,"price_display":"372.00","price_state":"stated","total_value":186000.0,"total_display":"186,000.00","shares_owned_after":6401.0,"shares_owned_after_display":"6,401","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-12","filed_date":"2014-02-14","scope":"insider"},{"id":6262329,"accession":"0001144204-14-010092","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001144204-14-010092","line_url":"/filing/0001144204-14-010092#line-4","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559537","owner_name":"Fundaro Paolo","owner_url":"/insider/0001559537","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":368.171,"price_display":"368.17","price_state":"stated","total_value":184085.5,"total_display":"184,085.50","shares_owned_after":8401.0,"shares_owned_after_display":"8,401","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-12","filed_date":"2014-02-14","scope":"insider"},{"id":6262322,"accession":"0001144204-14-010092","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001144204-14-010092","line_url":"/filing/0001144204-14-010092#line-3","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559537","owner_name":"Fundaro Paolo","owner_url":"/insider/0001559537","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":136.0,"shares_display":"136","price_per_share":379.7935,"price_display":"379.79","price_state":"stated","total_value":51651.916,"total_display":"51,651.92","shares_owned_after":3901.0,"shares_owned_after_display":"3,901","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-12","filed_date":"2014-02-14","scope":"insider"},{"id":4904429,"accession":"0001144204-13-045323","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001144204-13-045323","line_url":"/filing/0001144204-13-045323#line-4","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559537","owner_name":"Fundaro Paolo","owner_url":"/insider/0001559537","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3959.0,"shares_display":"3,959","price_per_share":46.1841,"price_display":"46.18","price_state":"stated","total_value":182842.8519,"total_display":"182,842.85","shares_owned_after":1330.0,"shares_owned_after_display":"1,330","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-08-12","filed_date":"2013-08-13","scope":"insider"},{"id":4904426,"accession":"0001144204-13-045323","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001144204-13-045323","line_url":"/filing/0001144204-13-045323#line-3","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559537","owner_name":"Fundaro Paolo","owner_url":"/insider/0001559537","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":800.0,"shares_display":"800","price_per_share":45.8868,"price_display":"45.89","price_state":"stated","total_value":36709.44,"total_display":"36,709.44","shares_owned_after":5289.0,"shares_owned_after_display":"5,289","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-08-12","filed_date":"2013-08-13","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":22,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":22,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":22},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001270073","name":"INTERCEPT PHARMACEUTICALS, INC.","url":"/issuer/0001270073","role":"Director, Ten percent owner","n_filings":8,"first_seen":"2013-08-13","last_seen":"2020-08-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001559537","retrieved_at":"2026-08-21T23:22:55+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}